A new case of Homer-3 autoimmunity has been described, expanding the still limited body of knowledge about this rare autoimmune cerebellar disorder. The case was reported in the Journal of Neuroimmunology in a collaboration between Euroimmun and Mayo Clinic (USA). What’s known so far To date, only 15 cases of Homer-3 autoantibody-associated disease have been […]

Autoimmunity targeting inositol 1,4,5-triphosphate receptor type 1 (ITPR1) was identified as a potential cause of cognitive decline resembling Alzheimer’s disease in a retrospective case study. The findings were reported by a research group from Norway and Germany in collaboration with Euroimmun. Patient with acute deterioration The study describes a 58-year-old patient who presented with acute

A new collaborative study by Euroimmun and researchers in Türkiye reports that both ELISA and immunoblot show excellent agreement with the reference standard — indirect immunofluorescence assay (IFA) — for serological staging of Epstein-Barr virus (EBV) infections. A widespread infection EBV is a ubiquitous herpesvirus that infects more than 95% of the global population, usually

Serological tests for coeliac disease-specific antibodies showed exceptionally high sensitivity and specificity in a Tunisian cohort, underscoring their diagnostic utility. The recently published findings stem from a collaborative study between Euroimmun and various laboratories in Tunisia. Studying a unique population Coeliac disease is an autoimmune disorder triggered in genetically predisposed individuals by gluten ingestion. It

A newly published international study has demonstrated the high sensitivity of the Euroimmun Dermal Binder Mosaic 1 for detecting antibodies against laminin β4, laminin 332 and collagen type VII. The prospective multicentre study represents the latest milestone in a long-standing research collaboration between Euroimmun and the University of Lübeck, Germany. Shedding light on anti-laminin β4